XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2022
FAIR VALUE MEASUREMENTS  
Schedule of investments measured at fair value

The following table presents investments (as shown on the consolidated schedule of investments) that were measured at fair value as of September 30, 2022:

    

Level 1

    

Level 2

    

Level 3

    

Total

First lien secured loans

$

$

$

615,945

$

615,945

Second lien secured loans

 

 

 

20,383

 

20,383

Subordinated unsecured loans

 

 

167

 

167

Subordinated Note to STRS JV

 

 

 

80,000

 

80,000

Equity (excluding STRS JV)

 

 

 

25,993

 

25,993

Equity in STRS JV(1)

 

 

 

 

22,066

Total investments

$

$

$

742,488

$

764,554

(1)The Company’s equity investment in STRS JV is measured using the net asset value per share as a practical expedient for fair value, and thus has not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated statements of assets and liabilities.

The following table presents investments (as shown on the consolidated schedule of investments) that were measured at fair value as of December 31, 2021:

    

Level 1

    

Level 2

    

Level 3

Total

First lien secured loans

$

$

$

697,232

$

697,232

Second lien secured loans

 

 

 

23,650

 

23,650

Subordinated Note to STRS JV

 

 

167

 

167

Subordinated Note to STRS JV

 

 

 

60,000

60,000

Equity (excluding STRS JV)

 

 

 

22,552

 

22,552

Equity in STRS JV(1)

 

 

 

 

15,607

Total investments

$

$

$

803,601

$

819,208

(1)The Company’s equity investment in STRS JV is measured using the net asset value per share as a practical expedient for fair value, and thus has not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated statements of assets and liabilities.
Schedule of changes in investments measured at fair value using Level 3 inputs

The following table presents the changes in investments measured at fair value using Level 3 inputs for the three and nine months ended September 30, 2022:

    

First Lien

    

Second Lien

    

    

Subordinated

    

    

Secured

Secured

Subordinated

Notes to STRS

Total

Three months ended September 30, 2022

Loans

Loans

Notes

JV

Equity

Investments

Fair value, beginning of period

$

614,859

$

22,063

 

$

167

$

80,000

$

27,111

$

744,200

Funding of investments

 

52,893

 

 

 

 

408

 

53,301

Non-cash interest income

 

594

 

3

 

 

 

 

597

Accretion of discount

 

1,039

 

21

 

 

 

 

1,060

Proceeds from paydowns and sales

 

(48,549)

 

 

 

 

(1,011)

 

(49,560)

Conversions

 

 

 

 

 

 

Realized gains (losses)

 

45

 

 

 

 

154

 

199

Net unrealized (depreciation) appreciation

 

(4,936)

 

(1,704)

 

 

 

(669)

 

(7,309)

Fair value, end of period

$

615,945

$

20,383

 

$

167

$

80,000

$

25,993

$

742,488

Change in unrealized appreciation (depreciation) on investments still held as of September 30, 2022

$

(4,689)

$

(1,702)

$

$

$

(384)

$

(6,775)

    

First Lien

    

Second Lien

    

    

Subordinated

    

    

Secured

Secured

Subordinated

Notes to STRS

Total

Nine months ended September 30, 2022

Loans

Loans

Notes

JV

Equity

Investments

Fair value, beginning of period

$

697,232

$

23,650

 

$

167

$

60,000

$

22,552

$

803,601

Funding of investments

 

222,667

 

 

 

20,000

 

1,085

 

243,752

Non-cash interest income

 

1,548

 

5

 

 

 

 

1,553

Accretion of discount (premium)

 

3,972

 

64

 

 

 

 

4,036

Proceeds from paydowns and sales

 

(293,935)

 

 

 

 

(2,862)

 

(296,797)

Conversions

 

(4,060)

 

 

 

 

4,060

 

Realized gains (losses)

 

(16,994)

 

(1,024)

 

 

 

1,919

 

(16,099)

Net unrealized (depreciation) appreciation

 

5,515

 

(2,312)

 

 

 

(761)

 

2,442

Fair value, end of period

$

615,945

$

20,383

 

$

167

$

80,000

$

25,993

$

742,488

Change in unrealized appreciation (depreciation) on investments still held as of September 30, 2022

$

(6,691)

$

(3,336)

$

$

$

(600)

$

(10,627)

The following table presents the changes in investments measured at fair value using Level 3 inputs for the three and nine months ended September 30, 2021:

    

First Lien

    

Second Lien

    

Subordinated

    

    

Secured

Secured

Subordinated

Notes to STRS

Total

Three months ended September 30, 2021

Loans

Loans

Notes

JV

Equity

Investments

Fair value, beginning of period

$

562,837

$

29,714

 

$

$

49,809

$

16,033

$

658,393

Funding of investments

 

135,497

 

 

167

 

7,488

 

2,278

 

145,430

Non-cash interest income

 

173

 

1

 

 

 

 

174

Accretion of discount

 

2,115

 

29

 

 

 

 

2,144

Proceeds from paydowns and sales

 

(133,361)

 

 

 

 

 

(133,361)

Realized gains

 

120

 

 

 

 

(11)

 

109

Net unrealized (depreciation) appreciation

 

(2,385)

 

(82)

 

 

 

1,888

 

(579)

Fair value, end of period

$

564,996

$

29,662

$

167

$

57,297

$

20,188

$

672,310

Change in unrealized appreciation (depreciation) on investments still held as of September 30, 2021

$

216

$

112

$

$

$

2,931

$

3,259

    

First Lien

    

Second Lien

    

Subordinated

    

    

Secured

Secured

Subordinated

Notes to STRS

Total

Nine months ended September 30, 2021

Loans

Loans

Notes

JV

Equity

Investments

Fair value, beginning of period

$

588,580

$

27,596

 

$

$

41,073

$

23,319

$

680,568

Funding of investments

 

310,749

 

14,550

 

498

 

16,224

 

2,938

 

344,959

Non-cash interest income

 

857

 

3

 

 

 

 

860

Accretion of discount

 

5,549

 

125

 

 

 

(25)

 

5,649

Proceeds from paydowns and sales

 

(341,177)

 

(12,670)

 

(331)

 

 

(9,442)

 

(363,620)

Realized losses

 

8,288

 

 

 

 

(574)

 

7,714

Net unrealized (depreciation) appreciation

 

(7,850)

 

58

 

 

 

3,972

 

(3,820)

Fair value, end of period

$

564,996

$

29,662

$

167

$

57,297

$

20,188

$

672,310

Change in unrealized appreciation (depreciation) on investments still held as of September 30, 2021

$

1,516

$

113

$

$

$

3,211

$

4,840

Schedule of Quantitative information about Level 3 fair value measurements

Fair Value as of

Valuation

Unobservable

Range

Investment Type

September 30, 2022

Techniques

Inputs

(Weighted Average)(1)

First lien secured loans

$

406,569

Discounted cash flows

Discount rate

7.5% – 19.9% (12.4%)

37,014

Recent transaction

Transaction price

82.0 – 99.1 (91.8)

111,055

Discounted cash flows and Recent transaction

Discount rate

7.6% – 13.5% (12.6%)

Transaction price

92.4 – 100.0 (97.9)

30,790

Discounted cash flows and Market quote

Discount Rate

10.5% – 11.8% (11.4%)

Market Quote

85.2 – 95.1 (90.7)

30,517

Expected repayment

Transaction price

100.0

$

615,945

Second lien secured loans

$

3,274

Discounted cash flows

Discount rate

17.4%

4,912

Discounted cash flows and Recent transaction

Transaction price

98.6

Discount rate

12.2%

12,197

Discounted cash flows and Market quote

Discount Rate

18.2%

Market Quote

77.8

$

20,383

Subordinated Notes

$

80,000

Enterprise value

167

Discounted cash flows

Discount Rate

4.1%

$

80,167

Preferred Equity

$

2,217

Discounted cash flows

Discount rate

24.3% – 25.5% (24.4%)

EBITDA Multiple

9.0x

816

Discounted cash flows and Enterprise value

Discount Rate

17.0%

EBITDA Multiple

3.6x - 8.5x (6.1x)

Discount for lack of marketability

15.0%

853

Enterprise value

Discount Rate

11.7%

$

3,886

Common Equity

$

1,614

Discounted cash flows

Discount rate

19.3% – 21.3% (21.1%)

EBITDA Multiple

7.5x

9,523

Discounted cash flows and Enterprise value

Discount Rate

12.0% – 19.4% (18.1%)

EBITDA Multiple

4.8 - 12.1 (9.3x)

361

Enterprise value

EBITDA Multiple

13.3x - 17.1x (15.2x)

Discount for lack of marketability

10.0%

219

Collateral value and Recent transaction

Transaction price

$1.30 per share

EBITDA Multiple

8.0x

Discount for lack of marketability

15.0%

2,471

Collateral value

EBITDA Multiple

6.0x – 10.0x (8.0x)

Discount for lack of marketability

15.0%

400

Recent transaction

Transaction price

$1.00 per share

1,264

Recent transaction and Enterprise value

Transaction price

$10.0 - 1,000.0 (482.4 per share)

EBITDA Multiple

5.0x – 12.3x (8.8x)

Discount for lack of marketability

15.0%

$

15,852

Warrant

3,823

Discounted cash flows and Option-pricing method

Discount rate

19.3%

EBITDA multiple

10.2x

Discount for lack of marketability

15.0%

2,432

Discounted cash flows

Discount Rate

0.5%

EBITDA Multiple

0.3x

Volatility

0.0%

Discount for lack of marketability

0.4%

$

6,255

Total Level 3 Investments

$

742,488

(1)Unobservable inputs were weighted by the relative fair value of the investments.

Fair Value as of

Valuation

Unobservable

Range

Investment Type

December 31, 2021

Techniques

Inputs

(Weighted Average)(1)

First lien secured loans

$

358,921

Discounted cash flows

Discount rate

4.5% – 21.8% (9.8%)

Exit EBITDA multiple

5.5x – 15.0x (8.3x)

209,892

Recent transaction

Transaction price

94.5 – 99.1 (97.9)

113,808

Discounted cash flows and Recent transaction

Discount rate

7.2% – 10.3% (8.6%)

Transaction price

97.5 – 98.8 (98.4)

Exit EBITDA multiple

7.0x – 11.0x (9.5x)

7,542

Guideline public companies

LTM EBITDA multiple

5.1x

7,069

Expected repayment

-

-

$

697,232

Second lien secured loans

$

18,725

Discounted cash flows

Discount rate

11.5% – 22.3% (14.2%)

Exit EBITDA multiple

6.5x – 8.5x (8.0x)

4,925

Recent transaction

Transaction price

98.5

$

23,650

Subordinated Notes

$

60,000

Enterprise value

-

-

167

Recent transaction

Transaction price

100.0

$

60,167

Preferred Equity

$

1,018

Similar transactions

LTM EBITDA multiple

9.7x

Discount for lack of marketability

15.0%

786

Discounted cash flows and Guideline public companies

Discount Rate

17.3%

Exit EBITDA Multiple

11.0x

LTM EBITDA Multiple

7.9x

NFY EBITDA Multiple

7.5x

Discount for lack of marketability

10.0%

1,007

Recent transaction

Transaction price

$1.00 – $56.30 ($47.13) per share

$

2,811

Common Equity

$

3,602

Discounted cash flows

Discount rate

13.0% – 22.7% (15.0%)

Exit EBITDA Multiple

8.6x – 10.0x (9.6x)

Discount for lack of marketability

10.0% – 15.0% (10.3%)

8,124

Discounted cash flows, Guideline public companies and Expected repayment

Discount rate

14.0% – 19.0% (18.2%)

Exit EBITDA Multiple

8.0x – 11.0x (10.5x)

NFY EBITDA Multiple

8.6x – 10.8x (8.9x)

Discount for lack of marketability

10.0%

Transaction price

$1.00 per share

2,052

Similar transactions

LTM EBITDA Multiple

6.0x – 13.4x (10.5x)

1,502

Recent transaction

Transaction price

$1.00 – $1,000.00 ($289.95) per share

$

15,280

Warrant

4,461

Discounted cash flows and Option-pricing method

Discount rate

22.7% – 29.5% (29.2%)

Exit EBITDA multiple

5.5x – 8.6x (5.9x)

Volatility

3.5% – 8.7% (3.6%)

Discount for lack of marketability

15.0%

$

4,461

Total Level 3 Investments

$

803,601

(1)Unobservable inputs were weighted by the relative fair value of the investments.
Schedule of principal amount and fair value of the Company's borrowings

As of September 30, 2022

As of December 31, 2021

Fair

Principal Amount

Principal Amount

    

Value Level

    

Outstanding

    

Fair Value

    

Outstanding

    

Fair Value

JPM Credit Facility

 

3

$

246,101

$

243,552

$

291,637

$

302,147

6.000% 2023 Notes

 

3

 

30,000

 

29,860

 

30,000

 

31,802

5.375% 2025 Notes

 

3

 

40,000

 

37,355

 

40,000

 

40,687

5.375% 2026 Notes

3

10,000

9,089

10,000

10,091

4.000% 2026 Notes

 

3

 

75,000

 

67,132

 

75,000

 

74,957

5.625% 2027 Notes

 

3

 

10,000

 

8,983

 

10,000

 

10,097

4.250% 2028 Notes

3

25,000

 

21,642

25,000

 

24,861

$

436,101

$

417,613

$

481,637

$

494,642